Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

Rodriguez A, Trigatti BL, Mineo C, Knaack D, Wilkins JT, Sahoo D, Asztalos BF, Mora S, Cuchel M, Pownall HJ, Rosales C, Bernatchez P, Ribeiro Martins da Silva A, Getz GS, Barber JL, Shearer GC, Zivkovic AM, Tietge UJF, Sacks FM, Connelly MA, Oda MN, Davidson WS, Sorci-Thomas MG, Vaisar T, Ruotolo G, Vickers KC, Martel C.

Arterioscler Thromb Vasc Biol. 2019 Oct 10:ATVBAHA119313340. doi: 10.1161/ATVBAHA.119.313340. [Epub ahead of print]

PMID:
31597448
2.

High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes.

Heier M, Ofstad AP, Borja MS, Brunborg C, Endresen K, Gullestad L, Birkeland KI, Johansen OE, Oda MN.

Atherosclerosis. 2019 Mar;282:183-187. doi: 10.1016/j.atherosclerosis.2018.07.005. Epub 2018 Jul 6.

3.

Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.

May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS.

J Biol Chem. 2018 Jun 15;293(24):9176-9187. doi: 10.1074/jbc.RA117.001099. Epub 2018 Apr 30.

4.

Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function.

Sarzynski MA, Ruiz-Ramie JJ, Barber JL, Slentz CA, Apolzan JW, McGarrah RW, Harris MN, Church TS, Borja MS, He Y, Oda MN, Martin CK, Kraus WE, Rohatgi A.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):943-952. doi: 10.1161/ATVBAHA.117.310307. Epub 2018 Feb 8. Erratum in: Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):e136.

5.

A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state.

Melchior JT, Walker RG, Cooke AL, Morris J, Castleberry M, Thompson TB, Jones MK, Song HD, Rye KA, Oda MN, Sorci-Thomas MG, Thomas MJ, Heinecke JW, Mei X, Atkinson D, Segrest JP, Lund-Katz S, Phillips MC, Davidson WS.

Nat Struct Mol Biol. 2017 Dec;24(12):1093-1099. doi: 10.1038/nsmb.3501. Epub 2017 Nov 13.

6.

Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis.

Choi HY, Ruel I, Malina A, Garrod DR, Oda MN, Pelletier J, Schwertani A, Genest J.

Eur Heart J. 2018 Apr 7;39(14):1194-1202. doi: 10.1093/eurheartj/ehx340.

PMID:
29106519
7.

Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.

Block RC, Holub A, Abdolahi A, Tu XM, Mousa SA, Oda MN.

Prostaglandins Leukot Essent Fatty Acids. 2017 Nov;126:25-31. doi: 10.1016/j.plefa.2017.08.016. Epub 2017 Sep 9.

8.

Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.

Angelovich TA, Hearps AC, Oda MN, Borja MS, Huynh D, Homann S, Jaworowski A, Kelesidis T.

AIDS. 2017 Nov 13;31(17):2331-2336. doi: 10.1097/QAD.0000000000001642.

9.

Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease.

Borja MS, Hammerson B, Tang C, Savinova OV, Shearer GC, Oda MN.

PLoS One. 2017 Aug 2;12(8):e0182217. doi: 10.1371/journal.pone.0182217. eCollection 2017.

10.

Reduced HDL function in children and young adults with type 1 diabetes.

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN.

Cardiovasc Diabetol. 2017 Jul 6;16(1):85. doi: 10.1186/s12933-017-0570-2.

11.

Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals.

Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):354-363. doi: 10.1097/QAI.0000000000001383.

12.

Lipid-free apoA-I structure - Origins of model diversity.

Oda MN.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Feb;1862(2):221-233. doi: 10.1016/j.bbalip.2016.11.010. Epub 2016 Nov 25. Review.

PMID:
27890580
13.

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Borja MS, Ng KF, Irwin A, Hong J, Wu X, Isquith D, Zhao XQ, Prazen B, Gildengorin V, Oda MN, Vaisar T.

J Lipid Res. 2015 Oct;56(10):2002-9. doi: 10.1194/jlr.M059865. Epub 2015 Aug 7.

14.

Increased high-density lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes.

Link JC, Chen X, Prien C, Borja MS, Hammerson B, Oda MN, Arnold AP, Reue K.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1778-86. doi: 10.1161/ATVBAHA.115.305460. Epub 2015 Jun 25.

15.

High-density lipoprotein cholesterol: origins and the path ahead.

Oda MN.

Curr Opin Endocrinol Diabetes Obes. 2015 Apr;22(2):133-41. doi: 10.1097/MED.0000000000000139. Review.

PMID:
25692918
16.

Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.

Ronsein GE, Pamir N, von Haller PD, Kim DS, Oda MN, Jarvik GP, Vaisar T, Heinecke JW.

J Proteomics. 2015 Jan 15;113:388-99. doi: 10.1016/j.jprot.2014.10.017. Epub 2014 Oct 31.

17.

Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus.

Stukas S, Robert J, Lee M, Kulic I, Carr M, Tourigny K, Fan J, Namjoshi D, Lemke K, DeValle N, Chan J, Wilson T, Wilkinson A, Chapanian R, Kizhakkedathu JN, Cirrito JR, Oda MN, Wellington CL.

J Am Heart Assoc. 2014 Nov 12;3(6):e001156. doi: 10.1161/JAHA.114.001156.

18.

Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.

Shao B, Tang C, Sinha A, Mayer PS, Davenport GD, Brot N, Oda MN, Zhao XQ, Heinecke JW.

Circ Res. 2014 May 23;114(11):1733-42. doi: 10.1161/CIRCRESAHA.114.303454. Epub 2014 Mar 19.

19.

NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.

Burgess BL, He Y, Baker MM, Luo B, Carroll SF, Forte TM, Oda MN.

Int J Nanomedicine. 2013;8:4733-43. doi: 10.2147/IJN.S50113. Epub 2013 Dec 12.

20.

HDL-apoA-I exchange: rapid detection and association with atherosclerosis.

Borja MS, Zhao L, Hammerson B, Tang C, Yang R, Carson N, Fernando G, Liu X, Budamagunta MS, Genest J, Shearer GC, Duclos F, Oda MN.

PLoS One. 2013 Aug 28;8(8):e71541. doi: 10.1371/journal.pone.0071541. eCollection 2013.

21.

Conservation of apolipoprotein A-I's central domain structural elements upon lipid association on different high-density lipoprotein subclasses.

Oda MN, Budamagunta MS, Geier EG, Chandradas SH, Shao B, Heinecke JW, Voss JC, Cavigiolio G.

Biochemistry. 2013 Oct 1;52(39):6766-78. doi: 10.1021/bi4007012. Epub 2013 Sep 17.

22.

The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy.

Oda MN, Budamagunta MS, Borja MS, Petrlova J, Voss JC, Lagerstedt JO.

FEBS J. 2013 Jul;280(14):3416-24. doi: 10.1111/febs.12334. Epub 2013 Jun 10.

23.

Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures.

Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P, Vaisar T.

Clin Chem. 2012 Apr;58(4):777-81. doi: 10.1373/clinchem.2011.173856. Epub 2012 Feb 3.

24.

Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I.

Hossain MA, Ngeth S, Chan T, Oda MN, Francis GA.

BMC Biochem. 2012 Jan 16;13:1. doi: 10.1186/1471-2091-13-1.

25.

The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy.

Lagerstedt JO, Budamagunta MS, Liu GS, DeValle NC, Voss JC, Oda MN.

Biochim Biophys Acta. 2012 Mar;1821(3):448-55. doi: 10.1016/j.bbalip.2011.12.010. Epub 2012 Jan 8.

26.

An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia.

Fan J, Stukas S, Wong C, Chan J, May S, DeValle N, Hirsch-Reinshagen V, Wilkinson A, Oda MN, Wellington CL.

J Lipid Res. 2011 Sep;52(9):1605-16. doi: 10.1194/jlr.M014365. Epub 2011 Jun 26.

27.

Imaging apolipoprotein AI in vivo.

Sriram R, Lagerstedt JO, Petrlova J, Samardzic H, Kreutzer U, Xie H, Kaysen GA, Desreux JF, Thonon D, Jacques V, Van Loan M, Rutledge JC, Oda MN, Voss JC, Jue T.

NMR Biomed. 2011 Aug;24(7):916-24. doi: 10.1002/nbm.1650. Epub 2011 Jan 24.

28.

Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins.

Lagerstedt JO, Cavigiolio G, Budamagunta MS, Pagani I, Voss JC, Oda MN.

J Biol Chem. 2011 Jan 28;286(4):2966-75. doi: 10.1074/jbc.M110.163097. Epub 2010 Nov 3.

29.

Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy.

Zhang L, Song J, Cavigiolio G, Ishida BY, Zhang S, Kane JP, Weisgraber KH, Oda MN, Rye KA, Pownall HJ, Ren G.

J Lipid Res. 2011 Jan;52(1):175-84. doi: 10.1194/jlr.D010959. Epub 2010 Oct 26.

30.

Assessment of the validity of the double superhelix model for reconstituted high density lipoproteins: a combined computational-experimental approach.

Jones MK, Zhang L, Catte A, Li L, Oda MN, Ren G, Segrest JP.

J Biol Chem. 2010 Dec 24;285(52):41161-71. doi: 10.1074/jbc.M110.187799. Epub 2010 Oct 25.

31.

A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties.

Burgess BL, Cavigiolio G, Fannucchi MV, Illek B, Forte TM, Oda MN.

Int J Pharm. 2010 Oct 31;399(1-2):148-55. doi: 10.1016/j.ijpharm.2010.07.057. Epub 2010 Aug 7.

32.

Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation.

Smoak KA, Aloor JJ, Madenspacher J, Merrick BA, Collins JB, Zhu X, Cavigiolio G, Oda MN, Parks JS, Fessler MB.

Cell Metab. 2010 Jun 9;11(6):493-502. doi: 10.1016/j.cmet.2010.04.006.

33.

Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.

Cavigiolio G, Geier EG, Shao B, Heinecke JW, Oda MN.

J Biol Chem. 2010 Jun 11;285(24):18847-57. doi: 10.1074/jbc.M109.098434. Epub 2010 Apr 12.

34.

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.

Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW.

J Biol Chem. 2010 Jun 11;285(24):18473-84. doi: 10.1074/jbc.M110.118182. Epub 2010 Apr 8.

35.

Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.

Shao B, Oda MN, Oram JF, Heinecke JW.

Chem Res Toxicol. 2010 Mar 15;23(3):447-54. doi: 10.1021/tx9003775. Review.

36.

A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL.

Wang XS, Shao B, Oda MN, Heinecke JW, Mahler S, Stocker R.

J Lipid Res. 2009 Mar;50(3):586-94. doi: 10.1194/jlr.D800042-JLR200. Epub 2008 Oct 2.

37.

Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12224-9. doi: 10.1073/pnas.0802025105. Epub 2008 Aug 21.

38.

Bridging across length scales: multi-scale ordering of supported lipid bilayers via lipoprotein self-assembly and surface patterning.

Vinchurkar MS, Bricarello DA, Lagerstedt JO, Buban JP, Stahlberg H, Oda MN, Voss JC, Parikh AN.

J Am Chem Soc. 2008 Aug 20;130(33):11164-9. doi: 10.1021/ja803110v. Epub 2008 Jul 22.

PMID:
18642906
39.

The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

Cavigiolio G, Shao B, Geier EG, Ren G, Heinecke JW, Oda MN.

Biochemistry. 2008 Apr 22;47(16):4770-9. doi: 10.1021/bi7023354. Epub 2008 Mar 27.

40.

Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.

Vaisar T, Shao B, Green PS, Oda MN, Oram JF, Heinecke JW.

Curr Atheroscler Rep. 2007 Nov;9(5):417-24.

PMID:
18001626
41.

Mapping the structural transition in an amyloidogenic apolipoprotein A-I.

Lagerstedt JO, Cavigiolio G, Roberts LM, Hong HS, Jin LW, Fitzgerald PG, Oda MN, Voss JC.

Biochemistry. 2007 Aug 28;46(34):9693-9. Epub 2007 Aug 1.

42.
43.

Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.

Shao B, Oda MN, Vaisar T, Oram JF, Heinecke JW.

Curr Opin Mol Ther. 2006 Jun;8(3):198-205. Review.

PMID:
16774039
44.

Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.

Shao B, Oda MN, Oram JF, Heinecke JW.

Curr Opin Cardiol. 2006 Jul;21(4):322-8. Review.

PMID:
16755201
45.

Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein.

Martin DD, Budamagunta MS, Ryan RO, Voss JC, Oda MN.

J Biol Chem. 2006 Jul 21;281(29):20418-26. Epub 2006 May 11.

46.

Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.

Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N, Oram JF, Heinecke JW.

J Biol Chem. 2006 Apr 7;281(14):9001-4. Epub 2006 Feb 22.

47.

Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.

Oda MN, Hargreaves PL, Beckstead JA, Redmond KA, van Antwerpen R, Ryan RO.

J Lipid Res. 2006 Feb;47(2):260-7. Epub 2005 Nov 28.

48.

Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain.

Beckstead JA, Block BL, Bielicki JK, Kay CM, Oda MN, Ryan RO.

Biochemistry. 2005 Mar 22;44(11):4591-9.

PMID:
15766290
49.

Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.

Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, Heinecke JW.

J Biol Chem. 2005 Feb 18;280(7):5983-93. Epub 2004 Nov 30.

50.

ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I.

Smith JD, Le Goff W, Settle M, Brubaker G, Waelde C, Horwitz A, Oda MN.

J Lipid Res. 2004 Apr;45(4):635-44. Epub 2004 Jan 1.

Supplemental Content

Support Center